ChromaDex (CDXC) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St recovers as yields ease; Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
ChromaDex Corporation Reports First Quarter 2019 Financial Results
May 9, 2019 4:01 PM EDT- First Quarter 2019 Net Revenues Increased by 53% to $10.0 Million -
First Quarter 2019 Highlights vs. First Quarter 2018
Strong start to the year with $10.0 million of net sales, higher gross margins and increased marketing efficiencyContinued progress building TRU NIAGEN into a global brand with top-line momentumTRU NIAGEN net sales were $7.5 million, a 15% increase sequentially and a 146% increase year-over-yearGlobal expansion continued with e-Commerce roll-out in Canada. Set foundation for initial Canadian retail launch with Showcase and WELL Health Technologies in AprilLOS ANGELES, May 09, 2019 (GLOBE NEWSWIRE)... More
